Top Clinical Trials companies in Hong Kong by Net Cash Used Provided By Financing Activities

This ranking features the top 2 Clinical Trials companies in Hong Kong ranked by Net Cash Used Provided By Financing Activities, totalling a Net Cash Used Provided By Financing Activities of USD 60.25 M, for January 16, 2025.

Hong Kong

Clinical Trials
Net Cash Used Provided By Financing Activities
#
Name
Net Cash Used Provided By Financing Activities
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
0013.HK

HUTCHMED (China) Limited

1

0013.HK
USD 48.66 M
Dec. 31, 2023 USD 3.02 2.59%

Hong Kong
2
3681.HK

SinoMab BioScience Limited

2

3681.HK
USD 11.59 M
Dec. 31, 2023 USD 0.13 -1.02%

Hong Kong
Frequently Asked Questions
  • Which Clinical Trials company in Hong Kong has the highest Net Cash Used Provided By Financing Activities ?

    The Clinical Trials company in Hong Kong with the highest Net Cash Used Provided By Financing Activities is HUTCHMED (China) Limited (HKSE: 0013.HK) at USD 48.66 M.

  • Which Clinical Trials company in Hong Kong has the lowest Net Cash Used Provided By Financing Activities ?

    The Clinical Trials company in Hong Kong with the lowest Net Cash Used Provided By Financing Activities is SinoMab BioScience Limited (HKSE: 3681.HK) at USD 11.59 M.

  • What are the top 10 Clinical Trials companies in Hong Kong by Net Cash Used Provided By Financing Activities ?

    The top 10 Clinical Trials companies in Hong Kong by Net Cash Used Provided By Financing Activities are HUTCHMED (China) Limited and SinoMab BioScience Limited.

  • What are the bottom 10 Clinical Trials companies in Hong Kong by Net Cash Used Provided By Financing Activities ?

    The bottom 10 Clinical Trials companies in Hong Kong by Net Cash Used Provided By Financing Activities are SinoMab BioScience Limited and HUTCHMED (China) Limited.